Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Critical Analysis: Ventas (VTR) and Healthcare Trust of America (NYSE:HTA)
Ventas (NYSE: VTR) and Healthcare Trust of America (NYSE:HTA) are both mid-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Volatility & Risk
Ventas has a beta of 0.07, indicating that its stock price is 93% less volatile than the S&P 500. Comparatively, Healthcare Trust of America has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500.
Profitability
This table compares Ventas and Healthcare Trust of America’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ventas | 20.08% | 6.31% | 2.81% |
| Healthcare Trust of America | 6.07% | 1.42% | 0.70% |
Valuation & Earnings
This table compares Ventas and Healthcare Trust of America’s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Ventas | $3.52 billion | 6.73 | $1.88 billion | $1.97 | 33.77 |
| Healthcare Trust of America | $504.67 million | 12.10 | $301.67 million | $0.21 | 144.95 |
Ventas has higher revenue and earnings than Healthcare Trust of America. Ventas is trading at a lower price-to-earnings ratio than Healthcare Trust of America, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Ventas and Healthcare Trust of America, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ventas | 3 | 7 | 0 | 0 | 1.70 |
| Healthcare Trust of America | 0 | 0 | 8 | 1 | 3.11 |
Ventas presently has a consensus target price of $62.33, suggesting a potential downside of 6.31%. Healthcare Trust of America has a consensus target price of $34.50, suggesting a potential upside of 13.34%. Given Healthcare Trust of America’s stronger consensus rating and higher possible upside, analysts clearly believe Healthcare Trust of America is more favorable than Ventas.
Dividends
Ventas pays an annual dividend of $3.10 per share and has a dividend yield of 4.7%. Healthcare Trust of America pays an annual dividend of $1.20 per share and has a dividend yield of 3.9%. Ventas pays out 157.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Healthcare Trust of America pays out 571.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has raised its dividend for 4 consecutive years and Healthcare Trust of America has raised its dividend for 6 consecutive years. Ventas is clearly the better dividend stock, given its higher yield and lower payout ratio.
Institutional & Insider Ownership
88.6% of Ventas shares are held by institutional investors. Comparatively, 70.9% of Healthcare Trust of America shares are held by institutional investors. 1.3% of Ventas shares are held by insiders. Comparatively, 1.5% of Healthcare Trust of America shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Ventas Company Profile
Healthcare Trust of America Company Profile